<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:973fe619-08bb-4111-a966-3b77a7174e4c,g:f35b4e6a-e8f0-4b57-857d-40aff24c69ea,d:1f98073cc85a4c66b2bf6c5112a3c4dc--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdxg-20201120</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY180L2ZyYWc6NmU4MjczMDQyNzgzNGM3Nzk0YzliYWZhYmRjNGE1YmYvdGFibGU6ZDI3NTllNmZjMDAwNGYyODk4ZTM0ZjQzZGMwNDhiMWEvdGFibGVyYW5nZTpkMjc1OWU2ZmMwMDA0ZjI4OThlMzRmNDNkYzA0OGIxYV8yLTEtMS0xLTA_43635124-f143-4127-880c-56d0bfdd7a06">0001376339</ix:nonNumeric><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY180L2ZyYWc6NmU4MjczMDQyNzgzNGM3Nzk0YzliYWZhYmRjNGE1YmYvdGFibGU6ZDI3NTllNmZjMDAwNGYyODk4ZTM0ZjQzZGMwNDhiMWEvdGFibGVyYW5nZTpkMjc1OWU2ZmMwMDA0ZjI4OThlMzRmNDNkYzA0OGIxYV80LTEtMS0xLTA_72fb0a77-9110-45c0-8ac9-b6555385c9fd">false</ix:nonNumeric><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY180L2ZyYWc6NmU4MjczMDQyNzgzNGM3Nzk0YzliYWZhYmRjNGE1YmYvdGFibGU6ZDI3NTllNmZjMDAwNGYyODk4ZTM0ZjQzZGMwNDhiMWEvdGFibGVyYW5nZTpkMjc1OWU2ZmMwMDA0ZjI4OThlMzRmNDNkYzA0OGIxYV83LTEtMS0xLTM3Mw_2aa4bb76-bbb3-4b56-8462-66d79eedb794">--12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdxg-20201120.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-23</xbrli:startDate><xbrli:endDate>2020-11-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1f98073cc85a4c66b2bf6c5112a3c4dc_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTE1_5a4987c3-7183-4ac1-a23b-8dac8225e785">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yNjY_4fe2921c-5bd5-47d5-a838-7615192dd0ae">November 20, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTE2_c32d291e-a965-43b9-bc6b-309d374a5b52">MIMEDX GROUP, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.539%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.305%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6YjFhMmM3NDhjYjZlNDI0OGIyNmNhNjZjN2I1MGVhMDQvdGFibGVyYW5nZTpiMWEyYzc0OGNiNmU0MjQ4YjI2Y2E2NmM3YjUwZWEwNF8wLTAtMS0xLTA_2a8e3b51-6d66-4bd6-97fb-46c49d38effe">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6YjFhMmM3NDhjYjZlNDI0OGIyNmNhNjZjN2I1MGVhMDQvdGFibGVyYW5nZTpiMWEyYzc0OGNiNmU0MjQ4YjI2Y2E2NmM3YjUwZWEwNF8wLTItMS0xLTA_cff01b67-6f6e-4d37-b7b4-2b07efe9e3d3">001-35887</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6YjFhMmM3NDhjYjZlNDI0OGIyNmNhNjZjN2I1MGVhMDQvdGFibGVyYW5nZTpiMWEyYzc0OGNiNmU0MjQ4YjI2Y2E2NmM3YjUwZWEwNF8wLTQtMS0xLTA_d3ba9d3b-32d1-4d86-ac00-d7822a1977d9">26-2792552</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTE3_2a18f4bf-421e-4f1e-af08-3d3927d44334">1775 West Oak Commons Ct., NE</ix:nonNumeric>, <ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTA5_921567de-754a-413d-b76f-566a64fd211c">Marietta</ix:nonNumeric> <ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTEy_f42f5103-73df-42e3-a519-15fb83978073">GA</ix:nonNumeric> <ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTEz_314f7ba1-2526-4d2e-8242-30e3fe15e2dd">30062</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTE0_eb12a63e-82eb-449e-9007-4b5ce2820384">770</ix:nonNumeric>) <ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTEw_4b74badf-baca-4085-aedd-086072064c5b">651-9100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.432%"><tr><td style="width:0.1%"></td><td style="width:2.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NGRjMDc4ZjhjYzIyNDg4OGFlZjg4NmEwZGI3MzZlNGMvdGFibGVyYW5nZTo0ZGMwNzhmOGNjMjI0ODg4YWVmODg2YTBkYjczNmU0Y18wLTAtMS0xLTA_55e453a2-1bb1-4d08-9345-59bfc8797692">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NGRjMDc4ZjhjYzIyNDg4OGFlZjg4NmEwZGI3MzZlNGMvdGFibGVyYW5nZTo0ZGMwNzhmOGNjMjI0ODg4YWVmODg2YTBkYjczNmU0Y18xLTAtMS0xLTA_703a070a-4ce4-43f1-a566-048c12c3aa0c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NGRjMDc4ZjhjYzIyNDg4OGFlZjg4NmEwZGI3MzZlNGMvdGFibGVyYW5nZTo0ZGMwNzhmOGNjMjI0ODg4YWVmODg2YTBkYjczNmU0Y18yLTAtMS0xLTA_bbf9cd7a-d06e-48eb-9b49-a68e6949a0e9">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NGRjMDc4ZjhjYzIyNDg4OGFlZjg4NmEwZGI3MzZlNGMvdGFibGVyYW5nZTo0ZGMwNzhmOGNjMjI0ODg4YWVmODg2YTBkYjczNmU0Y18zLTAtMS0xLTA_123c058b-4131-4eee-9fce-d53548dd6d58">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"></td><td style="width:27.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NzdlNGE0M2EyMWVjNDRhNDkxMzU3MWVmYWJmZDRmZDkvdGFibGVyYW5nZTo3N2U0YTQzYTIxZWM0NGE0OTEzNTcxZWZhYmZkNGZkOV8xLTAtMS0xLTIxNQ_bf8d9a99-60b1-4d8b-9cc1-d64ac625c772">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NzdlNGE0M2EyMWVjNDRhNDkxMzU3MWVmYWJmZDRmZDkvdGFibGVyYW5nZTo3N2U0YTQzYTIxZWM0NGE0OTEzNTcxZWZhYmZkNGZkOV8xLTItMS0xLTIxOA_124a3c77-30a0-491a-9018-ee4c2f684f24">MDXG</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGFibGU6NzdlNGE0M2EyMWVjNDRhNDkxMzU3MWVmYWJmZDRmZDkvdGFibGVyYW5nZTo3N2U0YTQzYTIxZWM0NGE0OTEzNTcxZWZhYmZkNGZkOV8xLTQtMS0xLTIyMA_f1221b62-c2f8-430b-8a5d-942a1893dc02">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6c754e37a5564fceae2f1ef229fb0591_D20201123-20201123" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFmOTgwNzNjYzg1YTRjNjZiMmJmNmM1MTEyYTNjNGRjL3NlYzoxZjk4MDczY2M4NWE0YzY2YjJiZjZjNTExMmEzYzRkY18xL2ZyYWc6NGNlMzNiNzk4ZjFlNGI4Y2JlZmUxZWMwYzgzNTBhNWEvdGV4dHJlZ2lvbjo0Y2UzM2I3OThmMWU0YjhjYmVmZTFlYzBjODM1MGE1YV8yMTEx_6e8cb26a-a59e-434b-aa0e-192f1e2e8ee5">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01&#160;&#160;&#160;&#160;Entry Into a Material Definitive Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2020, the Shareholders of MiMedx Group, Inc. (the &#8220;Company&#8221;) authorized amendments to the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (the &#8220;2016 Plan&#8221;). The 2016 Plan, as amended, is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. A description of the material terms of the 2016 Plan, and a copy of the 2016 Plan, were included in the Company&#8217;s definitive proxy statement filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on October 15, 2020, and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.03&#160;&#160;&#160;&#160;Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2020, the Shareholders of MiMedx Group, Inc. approved an amendment to the Company&#8217;s Articles of Incorporation (the &#8220;Articles of Amendment&#8221;) to increase the total number of authorized shares of the Company&#8217;s common stock from 150,000,000 shares ($.001 par value) to 187,500,000 shares ($.001 par value). A description of the Articles of Amendment and a copy of the Articles of Amendment were included in the Company&#8217;s definitive proxy statement filed with the SEC on October 15, 2020 and are incorporated herein by reference. Following approval by the shareholders, the Company filed Articles of Amendment with the Secretary of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> State of the State of Florida (&#8220;FL SOS&#8221;) on November 20, 2020 which were accepted by the FL SOS and became effective on November 23, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Articles of Amendment are filed hereto as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2020, MiMedx Group, Inc. (the "Company") held its 2020 Annual Meeting of shareholders (the &#8220;2020 Annual Meeting&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the 2020 Annual Meeting, shares of Company common stock and Series B Preferred Stock representing 100,524,031 votes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, approximately 77.3% of votes entitled to be cast at the 2020 Annual Meeting) were represented in person or by proxy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the 2020 Annual Meeting: (1) shareholders elected Michael J. Giuliani and Cato T. Laurencin as Class&#160;I directors; (2) shareholders approved the amendment to the Company's Articles of Incorporation to increase the number of shares of authorized common stock from 150,000,000 to 187,500,000; and (3) shareholders approved the amendments to the Company&#8217;s 2016 Equity and Cash Incentive Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below is information regarding the votes cast for each proposal:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proposal 1: Election of Class&#160;I Directors.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:20.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker&#160;Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. Giuliani</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,277,188</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,341,684</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,955</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,571,204</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cato T. Laurencin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,186,857</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,426,025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,945</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,571,204</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proposal 2: Approval of Amendment to the Company's Articles of Incorporation.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:20.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker&#160;Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shares Voted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,540,167</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,284,404</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699,460</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proposal 3: Approval of Amendments to the Company's 2016 Equity and Cash Incentive Plan.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.461%"><tr><td style="width:1.0%"></td><td style="width:20.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.959%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker&#160;Non-votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Shares Voted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,372,263</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,980,513</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,051</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,571,204</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01&#160;Other.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the 2020 Annual Meeting, (i) William A. Hawkins was appointed Chair of the Company&#8217;s Ethics and Compliance Committee, and (ii) Dr. Giuliani was added to the Ethics and Compliance Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the 2020 Annual Meeting, (i) Martin P. Sutter was appointed Chair of the Company&#8217;s Nominating and Corporate Governance Committee, and (ii) Dr. Laurencin was added to the Nominating and Corporate Governance Committee. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present composition of the committees of the Company&#8217;s Board of Directors is as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.690%"><tr><td style="width:1.0%"></td><td style="width:23.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.032%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Audit Committee</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Compensation Committee</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Ethics and Compliance Committee</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Nominating and Corporate Governance Committee</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">K. Todd Newton (Chair)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James L. Bierman</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James L. Bierman (Chair)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Martin P. Sutter</span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">William A. Hawkins (Chair)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael J. Giuliani</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">K. Todd Newton</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Martin P. Sutter (Chair)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">M. Kathleen Behrens</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cato T. Laurencin</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;Financial Statements and Exhibits.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.017%"><tr><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20201123mdxgform8-kex31.htm">Articles of Amendment to Articles of Incorporation</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20201123mdxgformex101.htm">2016 Equity and Cash Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:45.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.975%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.027%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MIMEDX GROUP, INC.</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 27, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter M. Carlson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson<br/>Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mdxg-20201120.htm", "description": "8-K", "secsgml_size_bytes": 61617}]
{"company-data": {"conformed-name": "MIMEDX GROUP, INC.", "cik": "0001376339", "assigned-sic": "3841", "irs-number": "262792552", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35887", "film-number": "201355384"}, "business-address": {"street1": "1775 W OAK COMMONS COURT, NE", "city": "MARIETTA", "state": "GA", "zip": "30062", "phone": "(770) 651-9100"}, "mail-address": {"street1": "1775 W OAK COMMONS COURT, NE", "city": "MARIETTA", "state": "GA", "zip": "30062"}, "former-company": {"former-conformed-name": "Alynx, Co.", "date-changed": "20060922"}}
mdxg-20201120
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________
FORM
8-K
____________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 20, 2020
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
Florida
001-35887
26-2792552
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
1775 West Oak Commons Ct., NE
,
Marietta
GA
30062
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (
770
)
651-9100
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
MDXG
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01    Entry Into a Material Definitive Agreement.
On November 20, 2020, the Shareholders of MiMedx Group, Inc. (the "Company") authorized amendments to the MiMedx Group, Inc. 2016 Equity and Cash Incentive Plan (the "2016 Plan"). The 2016 Plan, as amended, is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. A description of the material terms of the 2016 Plan, and a copy of the 2016 Plan, were included in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission ("SEC") on October 15, 2020, and are incorporated herein by reference.
Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On November 20, 2020, the Shareholders of MiMedx Group, Inc. approved an amendment to the Company's Articles of Incorporation (the "Articles of Amendment") to increase the total number of authorized shares of the Company's common stock from 150,000,000 shares ($.001 par value) to 187,500,000 shares ($.001 par value). A description of the Articles of Amendment and a copy of the Articles of Amendment were included in the Company's definitive proxy statement filed with the SEC on October 15, 2020 and are incorporated herein by reference. Following approval by the shareholders, the Company filed Articles of Amendment with the Secretary of
State of the State of Florida ("FL SOS") on November 20, 2020 which were accepted by the FL SOS and became effective on November 23, 2020
. The Articles of Amendment are filed hereto as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated herein by reference.
Item 5.07    Submission of Matters to a Vote of Security Holders.
On November 20, 2020, MiMedx Group, Inc. (the "Company") held its 2020 Annual Meeting of shareholders (the "2020 Annual Meeting").
At the 2020 Annual Meeting, shares of Company common stock and Series B Preferred Stock representing 100,524,031 votes (
i.e.
, approximately 77.3% of votes entitled to be cast at the 2020 Annual Meeting) were represented in person or by proxy.
At the 2020 Annual Meeting: (1) shareholders elected Michael J. Giuliani and Cato T. Laurencin as Class I directors; (2) shareholders approved the amendment to the Company's Articles of Incorporation to increase the number of shares of authorized common stock from 150,000,000 to 187,500,000; and (3) shareholders approved the amendments to the Company's 2016 Equity and Cash Incentive Plan.
Set forth below is information regarding the votes cast for each proposal:
Proposal 1: Election of Class I Directors.
For
Against
Abstain
Broker Non-votes
Michael J. Giuliani
55,277,188
3,341,684
333,955
41,571,204
Cato T. Laurencin
55,186,857
3,426,025
339,945
41,571,204
Proposal 2: Approval of Amendment to the Company's Articles of Incorporation.
For
Against
Abstain
Broker Non-votes
Total Shares Voted
86,540,167
13,284,404
699,460
N/A
Proposal 3: Approval of Amendments to the Company's 2016 Equity and Cash Incentive Plan.
For
Against
Abstain
Broker Non-votes
Total Shares Voted
49,372,263
8,980,513
600,051
41,571,204
Item 8.01 Other.
Immediately following the 2020 Annual Meeting, (i) William A. Hawkins was appointed Chair of the Company's Ethics and Compliance Committee, and (ii) Dr. Giuliani was added to the Ethics and Compliance Committee.
Immediately following the 2020 Annual Meeting, (i) Martin P. Sutter was appointed Chair of the Company's Nominating and Corporate Governance Committee, and (ii) Dr. Laurencin was added to the Nominating and Corporate Governance Committee.
The present composition of the committees of the Company's Board of Directors is as follows:
Audit Committee
Compensation Committee
Ethics and Compliance Committee
Nominating and Corporate Governance Committee
K. Todd Newton (Chair)
James L. Bierman
James L. Bierman (Chair)
Martin P. Sutter
William A. Hawkins (Chair)
Michael J. Giuliani
K. Todd Newton
Martin P. Sutter (Chair)
M. Kathleen Behrens
Cato T. Laurencin
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description of Exhibit
3.1
Articles of Amendment to Articles of Incorporation
10.1
2016 Equity and Cash Incentive Plan
104
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MIMEDX GROUP, INC.
Date: November 27, 2020
By:
/s/ Peter M. Carlson
Peter M. Carlson
Chief Financial Officer